Broad Pipeline of Differentiated
Product Candidates
to Fight Cancer & Autoimmune Disorders
Enrolling HER2+ Patients with
Metastatic Breast Cancer
in Phase 3 SOPHIA Study
Leading Multispecific Antibody
Technology Platforms
and Protein Engineering Expertise
Breakthrough Biologics,
Life-Changing
Medicines
Fully-integrated, Antibody-based
Development Capabilities,
Including GMP Manufacturing
Focused on Developing
Innovative Medicines
for Patients with Unmet Needs
Breakthrough Biologics,
Life-Changing
Medicines
Overview

We are a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer.

Corporate Fact Sheet

We’re Hiring!

It’s an exciting time at MacroGenics — we are building a new GMP manufacturing suite and looking for additional manufacturing and quality professionals to join our team. Our pipeline is expanding, as are our development and clinical teams.

Click on link below for current opportunities.

Latest News

MacroGenics to Present at Deutsche Bank Health Care Conference
Read More

MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results
Read More

Please note – you will leave a website owned by MacroGenics, Inc.

MacroGenics is not responsible for any content on the third party website.

Ok Close